CRIMINAL DEFENSE BLOG

blog
  • Posted by
  • Apr 20, 2023
  • 2 Comments

THE SCUTTLEBUTT FEATURING ARTICLES ABOUT CONFUSION OVER MEDICAL CANNABIS EXECUTIVE ORDER IN KENTUCKY, KEY FINDINGS IN SACRAMENTO CANNABIS CODE ENFORCEMENT AUDIT, FTC PROPOSES BANNING NON-COMPETE AGREEMENTS WITH WORKERS AND MORE

In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.

In today’s news:

#employmentlaw – “On January 5, the Federal Trade Commission (FTC) voted 3-1 to publish its Notice of Proposed Rulemaking, proposing a new rule that, if implemented, would bar employers from entering into noncompete agreements with their workers, and require employers to rescind existing noncompete restrictions with current and former workers. The proposed rule supersedes state laws that are less protective of employees, but keeps the state law that provides employees greater protection. The proposed rule excludes franchisees from the definition of “worker” and has a single, limited exception that applies to the sale of a business.”

https://www.lexology.com/library/detail.aspx?g=0b5990ca-8ded-4a0a-a1ca-04bfb76609fe&utm_source=Lexology+Daily+Newsfeed&utm_medium=HTML+email+-+Body+-+General+section&utm_campaign=Lexology+subscriber+daily+feed&utm_content=Lexology+Daily+Newsfeed+2023-01-10&utm_term=

#cannabislaw – “Global pharma giant Jazz Pharmaceuticals filed a lawsuit alleging that a list of generic drug companies infringed on its patents for Epidiolex, a cannabis-derived drug used to treat seizures from Dravet syndrome, tuberous sclerosis complex and Lennox-Gastaut syndrome.

The lawsuit, filed in a federal court in New Jersey, alleges that Alkem, Apotex, Teva Pharmaceuticals and other generic drugmakers submitted plans to market generic variations of Epidiolex to the U.S. Food and Drug Administration, according to financial media outlet Benzinga.”

https://mjbizdaily.com/jazz-pharma-lawsuit-alleges-generic-drugmakers-infringed-on-epidiolex-patents/

#californiacannabis – Sacramento – ” In the third annual report of the Continuous Cannabis Monitoring Reviews series, the Sacramento City Auditor took a closer look at the Cannabis Code Enforcement Unit within the city’s Community Development Department.

City councilmembers are set to accept the 2022/23 report at Tuesday’s meeting….

But one the audit’s four key findings showed some Cannabis Code Enforcement Unit data was inconsistent, or missing from its data management platform, CitizenServe.

The three other key findings include:

2 cannabis businesses were not being regularly inspected and some inspections were not performed timely.

Inspections could be strengthened with the use of checklists and standardized practices.

Management could promote efficiency and effectiveness through the use of performance metrics and documented reviews.”

https://www.abc10.com/article/news/local/sacramento/4-key-findings-cannabis-code-enforcement-unit-audit/103-738cba14-82f8-4238-9be3-1c8d409d96db

#cannabisindustry – “Days after Kentucky Gov. Andy Beshear’s executive order granting preemptive pardons for medical marijuana obtained out of state went into place on Jan. 1, confusion about how the order functionally operates continues, raising fears that Kentuckians legitimately seeking medical marijuana could still face criminal consequences.

One element potentially contributing to that confusion are the “palm cards” Beshear said would be distributed to law enforcement officers across the state to provide guidance on the executive order and what to do if they encountered someone with medical marijuana in their possession.”

https://www.leoweekly.com/2023/01/like-executive-order-palm-cards-guiding-law-enforcement-on-medical-marijuana-vague/